Revision 3
Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IHC-P

REACTIVITY:

H M R

SENSITIVITY:

Endogenous

MW (kDa):

45-65

Source/Isotype:

Rabbit IgG

UniProt ID:

#P02535, #P05784, #Q61781, #Q61414, #Q9Z2K1, #Q9QWL7, #P19001

Entrez-Gene Id:

16661, 16668, 16664, 16665, 16666, 16667, 16669

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunohistochemistry (Paraffin) 1:500 - 1:2000

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

For a carrier free (BSA and azide free) version of this product see product #72829.

Specificity / Sensitivity

Pan-Keratin (Type I) (E6S1S) Rabbit mAb recognizes endogenous levels of total type I keratin protein. The antibody was validated to detect overexpressed keratin 10, 17, and 18. By homology, it is also predicted to detect keratin 13, 14, 15, 16, and 19. It does not detect type II keratins including keratin 1, 5, 6a, 7, and 8. Non-specific staining was observed in Leydig cells of the testis by immunohistochemistry.

Species Reactivity:

Human, Mouse, Rat

Source / Purification

Monoclonal antibody is produced by immunizing animals with a mix of synthetic peptides corresponding to residues highly conserved among type I keratins.

Background

Keratins (cytokeratins) are intermediate filament proteins that are mainly expressed in epithelial cells. Keratin heterodimers composed of an acidic keratin (or type I keratin, keratins K9-K28) and a basic keratin (or type II keratin, keratins K1-K8 and K71-K80) assemble to form filaments. Keratin isoforms demonstrate tissue- and differentiation-specific profiles that make them useful as research and clinical biomarkers (1,2).

Dysregulation/mutations in keratin genes can lead to a variety of disorders affecting the skin, hair, nails, and other epithelial tissues (3). While expression of keratins can be variable, immunohistochemical staining of keratins is widely used to help in the identification and classification of epithelial tumors, and may also provide prognostic information.

Keratins 8 and 18 (K8/K18) are expressed in simple epithelia of normal tissue, as well as in adenocarcinomas of the breast, lung, ovary, and gastrointestinal tract. Keratin 17 is expressed in basal keratinocytes of stratified epithelia, hair follicles, and sebaceous glands. Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development (4). Keratin 14 (K14) is expressed in basal cells of stratified epithelia, and in basal-like subtypes of breast cancer and squamous cell carcinomas. Keratin 19 (K19) is expressed in glandular epithelia, including the liver, gallbladder, and pancreas, as well as in adenocarcinomas of the breast, thyroid, and bile duct. Keratin 20 (K20) is expressed in gastrointestinal epithelium, urothelium, and Merkel cells in the skin, as well as in colorectal carcinomas and some urothelial carcinomas. Keratin 5/6 (K5/6) is expressed in basal cells of stratified epithelia, including the skin, prostate, and breast, as well as in basal-like breast cancers, squamous cell carcinomas, and some lung carcinomas. Keratin 7 (K7) is expressed in glandular epithelia, such as those in the lung, breast, and female reproductive tract, as well as in adenocarcinomas of the lung, breast, and ovary (5,6).

Keratins, particularly K8, K18, and K19, serve as biomarkers for identification of circulating tumor cells (CTCs) (5).

Post-translational modifications, including phosphorylation, acetylation, ubiquitylation, sumoylation, glycosylation, and transamidation, have been shown to affect the functions of keratins in normal and disease states (6). Understanding the molecular mechanisms underlying these PTMs may provide insights into cancer pathogenesis.

  1. Chang, L. and Goldman, R.D. (2004) Nat Rev Mol Cell Biol 5, 601-13.
  2. Schweizer, J. et al. (2006) J Cell Biol 174, 169-74.
  3. Sarma, A. (2022) Int J Biol Macromol 219, 395-413.
  4. McGowan, K.M. and Coulombe, P.A. (1998) J Cell Biol 143, 469-86.
  5. Werner, S. et al. (2020) Mol Aspects Med 72, 100817.
  6. Dmello, C. et al. (2019) J Biosci 44, 33.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IHC-P: Immunohistochemistry (Paraffin)

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

限制使用

除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。

专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专

Revision 3
#83957

Pan-Keratin (Type I) (E6S1S) Rabbit mAb

Western Blotting Image 1: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb(上图)或 GAPDH (D16H11) XP® Rabbit mAb #5174(下图),对空载转染 (-) 或经表达全长人角蛋白 10 (hKRT10; +)、全长人角蛋白 17 (hKRT17; +) 或 Myc/DDK 标记的全长人角蛋白 18 (hKRT18-Myc/DDK; +) 的构建体转染的 293T 细胞的提取物进行蛋白质印迹分析。
Western Blotting Image 2: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb(上图)或 GAPDH (D16H11) XP® Rabbit mAb #5174(下图)对来自各种细胞系和组织的提取物进行蛋白质印迹分析。泛角蛋白(I 型)在 SUP-B15 细胞和 Jurkat 细胞中阴性表达与预测的表达模式一致。
Immunohistochemistry Image 1: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的人卵巢浆液性乳头状癌组织进行免疫组织化学分析。
Immunohistochemistry Image 2: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的人肾细胞癌组织进行免疫组织化学分析。
Immunohistochemistry Image 3: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的人鳞状细胞肺癌组织进行免疫组织化学分析。
Immunohistochemistry Image 4: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的人前列腺腺癌组织进行免疫组织化学分析。
Immunohistochemistry Image 5: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的人乳头状甲状腺癌组织进行免疫组织化学分析。
Immunohistochemistry Image 6: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的人宫颈鳞状细胞癌组织进行免疫组织化学分析。
Immunohistochemistry Image 7: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的人正常甲状旁腺组织进行免疫组织化学分析。
Immunohistochemistry Image 8: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的人正常胸腺组织进行免疫组织化学分析。
Immunohistochemistry Image 9: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的 Renca 同基因肿瘤组织进行免疫组织化学分析。
Immunohistochemistry Image 10: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的 4T1 同基因乳腺肿瘤组织进行免疫组织化学分析。
Immunohistochemistry Image 11: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的小鼠前胃组织进行免疫组织化学分析。
Immunohistochemistry Image 12: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对石蜡包埋的小鼠前列腺组织进行免疫组织化学分析。
Immunohistochemistry Image 13: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
与浓度匹配的 Rabbit (DA1E) mAb IgG XP® Isotype Control #3900(右图)比较,使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb(左图)对石蜡包埋的小鼠肝组织进行免疫组织化学分析。
Immunohistochemistry Image 14: Pan-Keratin (Type I) (E6S1S) Rabbit mAb Expand Image
使用 Pan-Keratin (Type I) (E6S1S) Rabbit mAb 对未转染(左上图)或各种人角蛋白转染的石蜡包埋的 293T 细胞沉淀物进行免疫组织化学分析。使用 Pan-Keratin (AE1/AE3) Mouse mAb #67306(插图)确认转染。